slotkoers
Taipei Exchange
00:00:00 19-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
43,75
TWD
|
+1,51%
|
|
+0,69%
|
-10,07%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
1.535
|
1.432
|
1.376
|
1.185
|
1.426
|
2.708
|
Bedrijfswaarde
1 |
2.308
|
2.240
|
2.057
|
1.853
|
2.071
|
3.200
|
K/w-verhouding
|
53,6
x
|
59,8
x
|
43,7
x
|
61,6
x
|
-114
x
|
116
x
|
Dividendrendement
|
-
|
0,75%
|
-
|
-
|
-
|
0,82%
|
Marktkapitalisatie/omzet
|
1,81
x
|
1,63
x
|
1,59
x
|
1,44
x
|
1,65
x
|
2,88
x
|
Bedrijfswaarde/omzet
|
2,72
x
|
2,55
x
|
2,38
x
|
2,25
x
|
2,39
x
|
3,4
x
|
Bedrijfswaarde/EBITDA
|
18,2
x
|
19,2
x
|
16,3
x
|
17,8
x
|
30,2
x
|
28,3
x
|
Bedrijfswaarde/FCF
|
-42,3
x
|
69,4
x
|
42,8
x
|
41,5
x
|
33,3
x
|
-22,9
x
|
FCF Yield
|
-2,37%
|
1,44%
|
2,33%
|
2,41%
|
3%
|
-4,37%
|
Price to Book
|
2,67
x
|
2,4
x
|
1,93
x
|
1,62
x
|
1,97
x
|
2,49
x
|
Aantal aandelen (in duizenden)
|
44.882
|
44.882
|
48.164
|
48.164
|
48.164
|
55.664
|
Referentieprijs
2 |
34,20
|
31,90
|
28,57
|
24,60
|
29,60
|
48,65
|
Datum van publicatie
|
30/04/19
|
30/04/20
|
26/04/21
|
27/04/22
|
27/04/23
|
30/04/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
849,9
|
877,9
|
866,1
|
824,1
|
866,3
|
939,9
|
EBITDA
1 |
126,6
|
116,9
|
126,4
|
104,2
|
68,53
|
113,1
|
Bedrijfsresultaat (EBIT)
1 |
52,33
|
45,24
|
57,12
|
40,1
|
5,945
|
53,31
|
Operationele Marge
|
6,16%
|
5,15%
|
6,6%
|
4,87%
|
0,69%
|
5,67%
|
Resultaat voor belastingen (EBT)
1 |
39,12
|
29,41
|
48,91
|
24,33
|
-4,714
|
38,68
|
Nettowinst (verlies)
1 |
28,65
|
24,12
|
31,4
|
19,23
|
-12,56
|
21,86
|
Nettomarge
|
3,37%
|
2,75%
|
3,63%
|
2,33%
|
-1,45%
|
2,33%
|
WPA
2 |
0,6380
|
0,5333
|
0,6536
|
0,3993
|
-0,2607
|
0,4200
|
Free Cash Flow
1 |
-54,58
|
32,25
|
48,03
|
44,62
|
62,13
|
-139,9
|
FCF-marge
|
-6,42%
|
3,67%
|
5,55%
|
5,41%
|
7,17%
|
-14,88%
|
Kasstroomconversie (ebitda)
|
-
|
27,58%
|
37,99%
|
42,84%
|
90,66%
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
133,73%
|
152,94%
|
231,98%
|
-
|
-
|
Dividend per aandeel
|
-
|
0,2381
|
-
|
-
|
-
|
0,4000
|
Datum van publicatie
|
30/04/19
|
30/04/20
|
26/04/21
|
27/04/22
|
27/04/23
|
30/04/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
773
|
808
|
681
|
668
|
646
|
492
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
6,103
x
|
6,91
x
|
5,39
x
|
6,416
x
|
9,424
x
|
4,354
x
|
Free Cash Flow
1 |
-54,6
|
32,3
|
48
|
44,6
|
62,1
|
-140
|
ROE (netto-inkomsten/eigen vermogen)
|
4,31%
|
3,13%
|
5,15%
|
2,4%
|
-0,85%
|
3,03%
|
ROA (netto-inkomsten/totale activa)
|
1,74%
|
1,49%
|
1,87%
|
1,31%
|
0,19%
|
1,59%
|
Totale activa
1 |
1.648
|
1.621
|
1.682
|
1.471
|
-6.582
|
1.375
|
Nettoactief per aandeel
2 |
12,80
|
13,30
|
14,80
|
15,20
|
15,00
|
19,60
|
Cashflow per aandeel
2 |
3,430
|
3,960
|
4,310
|
4,450
|
5,010
|
5,310
|
Capex
1 |
47
|
23,9
|
16
|
34,8
|
14,6
|
57,8
|
Capex/omzet
|
5,53%
|
2,72%
|
1,84%
|
4,23%
|
1,68%
|
6,15%
|
Datum van publicatie
|
30/04/19
|
30/04/20
|
26/04/21
|
27/04/22
|
27/04/23
|
30/04/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -10,07% | 74,06 mln. | | +52,93% | 803 mld. | | +40,98% | 629 mld. | | -7,08% | 351 mld. | | +17,40% | 324 mld. | | +10,58% | 303 mld. | | +16,42% | 244 mld. | | +2,17% | 226 mld. | | +10,66% | 215 mld. | | +6,24% | 164 mld. |
Farmaceutische producten - Andere
|